Alliance for Clinical Trials in Oncology: Pancreatic Neoplasms trials

The registry lists 20 Pancreatic Neoplasms studies with Alliance for Clinical Trials in Oncology as lead sponsor. 1 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 2Phase 2 14Phase 3 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
• Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT00733746Phase 2Results posted
• Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by SurgeryCompletedNCT00601627Phase 2Results posted
• Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00550836Phase 2Results posted
• The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic CancerActive, not recruitingNCT06115499Phase 2/3
• Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerActive, not recruitingNCT04340141Phase 3
• Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerCompletedNCT01821612Early Phase 1
• Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303CompletedNCT01664169
• Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerWithdrawnNCT01473303Phase 1/2
• Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic CancerCompletedNCT01327794
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2
• Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerCompletedNCT00059826Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerCompletedNCT00026403Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00026130Phase 2
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the PancreasCompletedNCT00012220Phase 2
• Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the PancreasCompletedNCT00006467Phase 2
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00004190Phase 2
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerCompletedNCT00003546Phase 2
• Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachCompletedNCT00003157Phase 1